Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 23 Mar 2022 for Inmune Bio, Inc., €136k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
James Kelly Ganjei: trading record in brief
Only one filing by James Kelly Ganjei is known so far (23 March 2022): a share grant, €136k, in Inmune Bio, Inc. That is too little to draw conclusions. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James Kelly Ganjei
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 17,793 shares@ US$8.43100.0% of flowCommon StockSEC:0001213900-22-014499:0
1 of 1 declaration